Today the pitch that’s been catching my eye is from Mitchell Clark for his Biotech Breakthrough Stock Report — we haven’t covered this newsletter before, but we have certainly covered teaser spiels from Mitchell Clark’s wide variety of Lombardi-published newsletters in the past (before he was a biotech expert this week, he was a bible […]
16 Comments Read MoreArticles
“Triple-Digit Profits from the Diabetic ‘Patch’ Company Going to $1 Billion.”
“Next Printing Press” Part Two, Five Breakthrough Companies teased by Patrick Cox
Well, yesterday we went through the first two picks that Patrick Cox is teasing as his “7 breakthrough companies” that will bring us our next “printing press moment” and change the world (while inflating your wallet). If you want to catch up with the rest of the group, that article is here. So let’s move […]
10 Comments Read MoreWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Allison: I find this company a little tough to size up...it is a holding company for several start-ups. It reminds me of...
Time to revisit some of the "dogs" in my portfolio…ACELRX PHARMACEUTICALS ($ACRX) - hopes to finish addressing th...
Anything associated "in name or referenced to" with Echo Therapeutics is enough for me to stay away! Thanks Dr. KSS and...
Frenchy: thanks for bringing it up. Personally, it sounds like they are trying to devise a Star Trek tricorder-like devi...
Om: I would still voice skepticism and doubt about FMI. No insider has ever bought a share, and insiders have been liqui...
Franklin: I agree. Brown is not precisely in a high-tech corridor, but a stunning number of companies are in the glucome...
Here's a tentative shorting list if anyone is interested. Be careful - I did it kinda fast. Maybe someone can clean it...
This is great news!!!! Echo Therapeutics Adds New Member to Board of Directors PHILADELPHIA, Feb. 28, 2014 /PRNewswire...
Brian Close: Let me help clarify a few points.ECTE is NOT targeting the diabetic market at the moment. It is target...